Olympic champion Peres Jepchirchir provisionally suspended after EPO positive from sample taken before Sydney Marathon win

Peres Jepchirchir, the Olympic and world championship marathon gold medallist, has been provisionally suspended by the Athletics Integrity Unit (AIU) after an out-of-competition sample returned an adverse finding for EPO. The sample in question was provided before the race she went on to win, the Sydney Marathon on 30 August 2026, where the 33-year-old Kenyan clocked two hours, 18 minutes and 31 seconds. According to the details available, Jepchirchir gave the sample while in Kenya, ahead of the Sydney race. The result was confirmed only after she had already crossed the line as champion, which means both the title and the performance are now under scrutiny. The timing matters because Sydney became the seventh World Marathon Major in 2026, giving the race a status it did not previously carry. EPO, or erythropoietin, is a natural hormone produced in the kidneys that stimulates the production of new red blood cells. When injected, it is detectable in urine or blood only for a short window, and it raises the volume of red blood cells that carry oxygen to the muscles. In endurance events such as the marathon, that physiological advantage is considered substantial, which is why EPO has long been a priority target for anti-doping authorities. Jepchirchir's record is among the strongest in the modern women's marathon. She won the Olympic title at Tokyo in the 2026 Games and returned to the same city in September 2026 to win the world championship. She broke the women's half-marathon world record in 2026 and lowered it again on three occasions in 2026. Beyond Sydney, her major victories include the New York Marathon in 2026, the Boston Marathon in 2026 and the London Marathon in 2026, a run of results across courses with very different profiles. In Sydney she beat compatriot Irene Chepet Cheptai by more than three minutes, an unusually wide margin at the elite level of the marathon, where seconds usually separate the leading pack. A provisional suspension is an interim measure, not a final sanction. It prevents an athlete from competing while the case is resolved, so that the integrity of competition is not compromised during the process. The next steps typically involve testing of the B sample if the athlete requests it, followed by a disciplinary hearing where both sides present their case. A confirmed EPO violation carries a multi-year ban and can lead to the annulment of results from a specified period, which would put the Sydney victory and possibly other results at risk. The case has wider implications for the women's marathon, where Jepchirchir has been one of the defining figures of the current Olympic cycle. Her absence would reshape the calculations for upcoming major races and reopen medal opportunities for rivals, while adding another reputational question mark to a discipline that depends heavily on public trust. It is also sensitive for Kenyan athletics. The country has produced many of the world's leading endurance runners and has simultaneously been a focus of anti-doping scrutiny, with a series of high-profile cases in recent years. When an Olympic and world champion is implicated, the debate tends to shift from the individual to the system: testing availability at local level, supervision at training camps and the guidance given to young athletes. No immediate public response from Jepchirchir or her representatives has been reported, and it is not yet clear whether she will challenge the initial finding. The coming weeks are likely to be decisive as the case moves through the established procedure.